290 related articles for article (PubMed ID: 26285577)
1. Macular hole formation following intravitreal injection of ranibizumab for branch retinal vein occlusion: a case report.
Muramatsu D; Mitsuhashi R; Iwasaki T; Goto H; Miura M
BMC Res Notes; 2015 Aug; 8():358. PubMed ID: 26285577
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ranibizumab and subthreshold micropulse laser in treatment of macular edema secondary to branch retinal vein occlusion.
Buyru Özkurt Y; Akkaya S; Aksoy S; Şimşek MH
Eur J Ophthalmol; 2018 Nov; 28(6):690-696. PubMed ID: 29696993
[TBL] [Abstract][Full Text] [Related]
3. Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edema.
Noma H; Yasuda K; Shimura M
Eur J Ophthalmol; 2021 Jan; 31(1):204-210. PubMed ID: 31690095
[TBL] [Abstract][Full Text] [Related]
4. The laser combined with intravitreal injection of ranibizumab for treatment of macular edema secondary to branch retinal vein occlusion: A protocol for systematic review and meta-analysis.
Chen G; Chen P; Chen X; Wang J; Peng X
Medicine (Baltimore); 2021 Jan; 100(4):e23675. PubMed ID: 33530168
[TBL] [Abstract][Full Text] [Related]
5. SHORT-TERM EFFECT OF INTRAVITREAL RANIBIZUMAB THERAPY ON MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION.
Minami Y; Nagaoka T; Ishibazawa A; Yoshida A
Retina; 2016 Sep; 36(9):1726-32. PubMed ID: 26866527
[TBL] [Abstract][Full Text] [Related]
6. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
[TBL] [Abstract][Full Text] [Related]
7. FULL-THICKNESS MACULAR HOLE FORMATION AND SPONTANEOUS CLOSURE DURING INTRAVITREAL RANIBIZUMAB THERAPY FOR CENTRAL RETINAL VEIN OCCLUSION.
Goel N
Retin Cases Brief Rep; 2022 Nov; 16(6):678-680. PubMed ID: 33165304
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion.
Risard SM; Pieramici DJ; Rabena MD; Basefsky JC; Avery RL; Castellarin AA; Nasir MA; See RF; Couvillion SS
Retina; 2011 Jun; 31(6):1060-7. PubMed ID: 21283055
[TBL] [Abstract][Full Text] [Related]
11. RANIBIZUMAB FOR RETINAL VEIN OCCLUSION: Predictive Factors and Long-Term Outcomes in Real-Life Data.
Chatziralli I; Theodossiadis G; Chatzirallis A; Parikakis E; Mitropoulos P; Theodossiadis P
Retina; 2018 Mar; 38(3):559-568. PubMed ID: 28248827
[TBL] [Abstract][Full Text] [Related]
12. The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion.
Lehmann-Clarke L; Dirani A; Mantel I; Ambresin A
Klin Monbl Augenheilkd; 2015 Apr; 232(4):552-5. PubMed ID: 25902119
[TBL] [Abstract][Full Text] [Related]
13. Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.
Pielen A; Mirshahi A; Feltgen N; Lorenz K; Korb C; Junker B; Schaefer C; Zwiener I; Hattenbach LO;
Acta Ophthalmol; 2015 Feb; 93(1):e29-37. PubMed ID: 25042729
[TBL] [Abstract][Full Text] [Related]
14. SURGICAL MANAGEMENT OF FULL-THICKNESS MACULAR HOLE SUPERIMPOSED ON EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Shif OA; Katz MSJ
Retin Cases Brief Rep; 2021 May; 15(3):211-213. PubMed ID: 30095597
[TBL] [Abstract][Full Text] [Related]
15. Pars plana vitrectomy with multiple transvenous chorioretinotomies for macular edema due to retinal vein occlusion.
Luttrull JK; Spink CJ
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(4):366-73. PubMed ID: 23883532
[TBL] [Abstract][Full Text] [Related]
16. Response of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusion.
Mylonas G; Sacu S; Dunavoelgyi R; Matt G; Blum R; Buehl W; Pruente C; Schmidt-Erfurth U;
Retina; 2013 Jun; 33(6):1220-6. PubMed ID: 23584689
[TBL] [Abstract][Full Text] [Related]
17. CHOROIDAL BLOOD FLOW AND THICKNESS AS PREDICTORS FOR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.
Okamoto M; Yamashita M; Sakamoto T; Ogata N
Retina; 2018 Mar; 38(3):550-558. PubMed ID: 28234806
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ehlers JP; Decroos FC; Fekrat S
Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
[TBL] [Abstract][Full Text] [Related]
19. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
Nagaoka T; Sogawa K; Yoshida A
Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
[TBL] [Abstract][Full Text] [Related]
20. A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.
Narayanan R; Panchal B; Das T; Chhablani J; Jalali S; Ali MH;
Br J Ophthalmol; 2015 Jul; 99(7):954-9. PubMed ID: 25631483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
